SMTL ID : 8cyh.1

Novel Anti-Mesothelin Antibodies Enable Crystallography of the Intact Mesothelin Ectodo- main and Engineering of Potent, T cell-engaging Bispecific Therapeutics

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.38 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 2 residues within 4Å: Chain C: Q.226, N.228 No protein-ligand interaction detected (PLIP) NAG.2: 1 residues within 4Å: Chain C: N.93 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lin, I. et al., Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics. Front. Drug Discov. (2023)

Release Date

2023-06-07

Peptides

A12 antibody light chain: A
A12 antibody heavy chain: B
Mesothelin, cleaved form: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
M

A12 antibody light chain

A12 antibody heavy chain

Mesothelin, cleaved form

Related Entries With Identical Sequence